Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Rowe

Showing results (291-300 of 459) with videos related to

Pageof 46
Sort By:
Annals of Neurology|November 2, 2022
Synaptic Loss in Frontotemporal Dementia Revealed by [<sup>11</sup> C]UCB-J Positron Emission TomographyMaura Malpetti, P Simon Jones, Thomas E Cope, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Brain : a Journal of Neurology|March 8, 2023
Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementiaMaura Malpetti, Thomas E Cope, Duncan Street, et al.
Brain : a Journal of Neurology|March 4, 2025
Post-mortem validation of in vivo TSPO PET as a microglial biomarkerSasvi S Wijesinghe, James B Rowe, Hannah D Mason, et al.
Neurobiology of Aging|April 22, 2017
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's diseaseElijah Mak, Li Su, Guy B Williams, et al.
Brain Communications|December 19, 2025
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsyNoah L Shapiro, Peter Simon Jones, Elijah Mak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Alzheimer's disease and its progression reduce pyramidal cell gain and connectivityJuliette H Lanskey, Amirhossein Jafarian, Melek Karadag, et al.
Neuroimage. Clinical|December 1, 2022
Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort studyKamen A Tsvetanov, Lennart R B Spindler, Emmanuel A Stamatakis, et al.
Neurobiology of Aging|February 25, 2021
In vivo coupling of dendritic complexity with presynaptic density in primary tauopathiesElijah Mak, Negin Holland, P Simon Jones, et al.
Annals of Clinical and Translational Neurology|January 19, 2017
[<sup>18</sup>F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutationW Richard Bevan Jones, Thomas E Cope, Luca Passamonti, et al.
Pageof 46

Showing results (291-300 of 459) with videos related to

Sort By:
Pageof 46
Annals of Neurology|November 2, 2022
Synaptic Loss in Frontotemporal Dementia Revealed by [<sup>11</sup> C]UCB-J Positron Emission TomographyMaura Malpetti, P Simon Jones, Thomas E Cope, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Brain : a Journal of Neurology|March 8, 2023
Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementiaMaura Malpetti, Thomas E Cope, Duncan Street, et al.
Brain : a Journal of Neurology|March 4, 2025
Post-mortem validation of in vivo TSPO PET as a microglial biomarkerSasvi S Wijesinghe, James B Rowe, Hannah D Mason, et al.
Neurobiology of Aging|April 22, 2017
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's diseaseElijah Mak, Li Su, Guy B Williams, et al.
Brain Communications|December 19, 2025
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsyNoah L Shapiro, Peter Simon Jones, Elijah Mak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Alzheimer's disease and its progression reduce pyramidal cell gain and connectivityJuliette H Lanskey, Amirhossein Jafarian, Melek Karadag, et al.
Neuroimage. Clinical|December 1, 2022
Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort studyKamen A Tsvetanov, Lennart R B Spindler, Emmanuel A Stamatakis, et al.
Neurobiology of Aging|February 25, 2021
In vivo coupling of dendritic complexity with presynaptic density in primary tauopathiesElijah Mak, Negin Holland, P Simon Jones, et al.
Annals of Clinical and Translational Neurology|January 19, 2017
[<sup>18</sup>F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutationW Richard Bevan Jones, Thomas E Cope, Luca Passamonti, et al.
Pageof 46